logo

Sector: Pharmaceuticals & Biotechnology

|

Small Cap

Venus Remedies Share Price

Venus Remedies Ltd.

661

-11.40(-1.70%)
2nd Mar 2026 | 3:27 PM
NSE : VENUSREM
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Venus Remedies Performance

Price Movement

₹661.00

₹640.00

₹668.00

Today's LowToday's High

1 Year Performance

₹661.00

₹277.95

₹839.95

52 Week Low52 Week High

Markets Today

High₹668.00
Low₹640.00
Open at₹646.00
Prev Close₹672.40
Volumes57.70 K
Avg Price₹651.91
Lower Circuit₹638.80
Upper Circuit₹706.00

Historical Performance

3M High₹839.95
3M Low₹640.00
1 Yr High₹839.95
1 Yr Low₹277.95
3 Yr High₹839.95
3 Yr Low₹151.05
5 Yr High₹839.95
5 Yr Low₹145.80

Venus Remedies Fundamentals

Market Cap
Above industry Median
870.80 Cr.
PE Ratio (TTM)
Below industry Median
11.40
Dividend Yield
0
Net Profit TTM
119.0% incr over last year
76.31
Net Profit Growth
119.0% incr over last year
76.31
PEG Ratio
Below industry Median
0.10
ROE
38.2% incr over last year
8.07
Operating Revenue TTM
699.88
Operating Revenue Growth
8.0% incr over last year
Book Value
Below industry Median
1.40
MFI
MFI is mid-range
36.51
RSI
RSI is mid-range
32.80
EPS (TTM)
33.90
Debt to Equity
0
Face Value
10
Operating Profit Margin Qtr.
9.50
Operating Profit Qtr.
37.52
Net Profit Qtr.
25.58
Operating Revenue Qtr.
180.26
PB Ratio
1.40

Venus Remedies Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue179.95192.65131.85194.04172.54
Operating Expense143.23162.81119.20171.49149.63
Operating Profit36.7229.8412.6522.5522.91
Depreciation6.325.925.954.495.20
Interest00000
Tax7.896.363.0110.045.28
Net Profit24.9219.2411.6914.7924.08

Venus Remedies Technicals

Venus Remedies Ltd. EMA & SMA

661.00

-11.40 (-1.70%)

Bullish Moving Average

3

Bearish Moving Average

13

Day EMA5 ₹682.3
Day EMA10 ₹705.5
Day EMA12 ₹711.4
Day EMA20 ₹725.7
Day EMA26 ₹730.9
Day EMA50 ₹726.9
Day EMA100 ₹677.9
Day EMA200 ₹590.6

Venus Remedies Support and Resistance

Resistance

First Resistance₹666.30
Second Resistance₹681.15
Third Resistance₹694.30

Support

First Support₹638.30
Second Support₹625.15
Third Support₹610.30

Technical Indicators

Day RSI32.80
Day MFI36.51
Day ADX14.29
Day Commodity Channel Index-198.30
William-93.04
Day MACD-19.52
Day MACD Signal Line-8.03
Day ATR37.67
Day ROC12543.16
Day ROC21-19.86

Venus Remedies Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter41.841.841.841.841.841.8
FII1.21.11.32.21.92.2
DII0.1000.20.71.1
Public56.957.156.955.955.655

Venus Remedies Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day59.28 K59.28 K100.00%
Week46.31 K46.31 K100.00%
1 Month28.34 K28.34 K100.00%
6 Month39.18 K66.01 K59.36%

Venus Remedies SWOT Analysis

Strengths29
Weakness5
Opportunity1
Threats1

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Strong Performer, Under Radar Stocks (DVM)

Newly Affordable Stocks with Good Financials and Durability (subscription)

Undervalued Growth Stocks

Consistent high performing stocks over Five Years

Stocks seeing month price declines, good financial durability, and newly affordable valuations (subscription)

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

Best Bargains Screener: Above line growth, Below line valuations

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Companies with rising net profit margins - quarterly as well as TTM basis

Affordable Stocks - Stocks with Good Valuation Score

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Highest Recovery from 52 Week Low

Volume Shockers

Venus Remedies Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
23 Sep, 20133FINALEquity Share
20 Sep, 20123FINALEquity Share
22 Sep, 20113FINALEquity Share
23 Sep, 20103FINALEquity Share
17 Sep, 20093FINALEquity Share
12 Sep, 20084FINALEquity Share
18 Sep, 20073FINALEquity Share
21 Sep, 20062FINALEquity Share
03 Feb, 20051INTERIM04 Feb, 2005Equity Share

Venus Remedies Stock Comparison

Financials
Price (₹)₹7.20₹100.40₹110.90₹581.95₹767.95₹666
% Change-4.89%-2.48%2.19%-2.48%0.40%-0.34%
Revenue TTM (₹ Cr)₹104.12₹282.74-₹488.20₹588.52₹1,496.96
Net Profit TTM (₹ Cr)₹-24.37₹15.30-₹56.90₹101.60₹132.41
PE TTM-2.4025.40-29.5034.7028.70
1 Year Return620-20.4422.590.5840.59-8.49
ROCE-5.63--23.879.3414.12

FAQ's on VENUSREM

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy